Journal Article > CommentaryAbstract Only
J Clin Endocrinol Metab
. 2022 May 27; Volume 107 (Issue 9); e3553-e3561.; DOI:10.1210/clinem/dgac331
Kehlenbrink S, Ansbro É, Besançon S, Hassan S, Roberts B, et al.
J Clin Endocrinol Metab
. 2022 May 27; Volume 107 (Issue 9); e3553-e3561.; DOI:10.1210/clinem/dgac331
Amid the growing global diabetes epidemic, the scale of forced displacement resulting from armed conflict and humanitarian crises is at record-high levels. More than 80% of the displaced population lives in lower- and middle-income countries, which also host 81% of the global population living with diabetes. Most crises are protracted, often lasting decades, and humanitarian aid organizations are providing long-term primary care to both the local and displaced populations. Humanitarian crises are extremely varied in nature and occur in contexts that are diverse and dynamic. The scope of providing diabetes care varies depending on the phase of the crisis. This paper describes key challenges and possible solutions to improving diabetes care in crisis settings. It focuses on (1) ensuring a reliable supply of life preserving medications and diagnostics, (2) restoring and maintaining access to health care, and (3) adapting service design to the context. These challenges are illustrated through case studies in Ukraine, Mali, the Central African Republic, and Jordan.